This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Dr. Helena Francis, PhD
VP of Corporate Development at Constructive Bio
Speaker

Profile

Helena is VP of Corporate Development at Constructive Bio: a Cambridge-based engineering biology spin-out that rewrites genomes to build and manufacture the biomolecules of the future. Helena shapes the firm’s funding, strategy and corporate growth. In 2024, Helena supported the company’s $58 million Series A fundraise and secured the company’s first Innovate UK funding with CPI.

Helena has a bachelor’s and master’s in Natural Sciences (Biochemistry) from the University of Cambridge and a PhD in Genetics from the University of Oxford. Helena trained as a Management Consultant at Oliver Wyman before transitioning into biotech as Head of Business Development at London-based Bactobio.

Agenda Sessions

  • Biology vs. New-to-nature Chemistries: Constructing the Next Generation of Therapeutic Peptides with An Expanded Genetic Code

    16:30